F1D8N1 (F1D8N1_HUMAN) Homo sapiens (Human)

Liver X nuclear receptor alpha variant 1 UniProtKBInterProInteractive Modelling

447 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: Q13133; Pan troglodytes: A0A6D2XX46, K7AUZ1; Pan paniscus: A0A2R9BV37

Available Structures

7 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 32b Heteromer
Q13133; Q15788;
204-447
100.04KQ;
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4 Heteromer
Q13133; Q15788;
204-446
100.04KM;
Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease Heteromer
Q13133; Q15788;
205-446
100.0668;SO4;
X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha Heteromer
Q13133; Q15788;
205-446
100.0SO4;O90;
X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha Heteromer
Q13133; Q15788;
204-445
100.0O40;SO4;
X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha Heteromer
Q13133; Q15788;
205-445
100.0965;SO4;
Crystal structure of the LXRalfa-RXRbeta LBD heterodimer Heteromer
P28702; Q13133; Q15596;
207-445
100.0MEI;444;

12 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4nqa.1.Bmonomer0.7485-444
ZN;73.70
4nqa.2.Bmonomer0.7486-445
ZN;965;73.70
5uan.1.Bmonomer0.6597-444
ZN;34.23
7wnh.4.Amonomer0.6298-444
ZN;29.43
7wnh.2.Amonomer0.6197-443
ZN;29.43
3dzy.1.Bmonomer0.6195-445
ZN;28.65
4iqr.2.Bmonomer0.5796-444
ZN;30.72
4iqr.2.Amonomer0.5796-444
ZN;30.72
7prw.1.Bmonomer0.5795-446
ZN;24.25
3dzy.1.Amonomer0.5295-430
ZN;31.09
5uan.1.Amonomer0.5297-430
ZN;31.49
4nqa.2.Amonomer0.5197-430
ZN;31.49